Functional changes in dopamine D3 receptors by prenatal and neonatal exposure to an endocrine disruptor bisphenol-A in mice

Addiction Biology

Volumn 9, Issue 1, 2004, Pages 19-25

  Mizuo, Keisuke ^a   Narita, Minoru ^a   Yoshida, Takuya ^a   Narita, Michiko ^a   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 4,4' ISOPROPYLIDENEDIPHENOL; DOPAMINE 3 RECEPTOR; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FOREBRAIN; ISOTOPE LABELING; LIMBIC CORTEX; MALE; MESENCEPHALON; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANIMALS, NEWBORN; DOPAMINE AGONISTS; EMBRYO; ESTROGENS, NON-STEROIDAL; GTP-BINDING PROTEINS; LIMBIC SYSTEM; MALE; MICE; PHENOLS; PROSENCEPHALON; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAHYDRONAPHTHALENES;

EID: 2342535738     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210410001674059     Document Type: Article

References (19)

1. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. Exposure to bisphenol-A advances puberty. Nature 1999;401: 763-4.
2. Suzuki T, Mizuo K, Nakazawa H, et al. Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state. Neuroscience 2003;117:639-44.
3. Sokoloff P, Giros B, Martres M-P, Bouthnet M-L, Schwanz J-C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990;347:146-51.
4. Suzuki T, Maeda J, Funada M, Misawa M. The D3-receptor agonist (+/-)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice. Neurosci Lett 1995;187:45-8.
5. De Boer P, Enrico P, Wright J, et al. Characterization of the effect of dopamine D3 receptor stimulation on locomotion and striatal dopamine levels. Brain Res 1997;758:83-91.
6. Narita M, Mizuo K, Mizoguchi H, et al. Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion. J Neurosci 2003;23:1006-12.
7. Narita M, Suzuki T, Funada M, Misawa M, Nagase H. Blockade of the morphine-induced increase in turnover of dopamine on the mesolimbic dopaminergic system by κ-opioid receptor activation in mice. Life Sci 1992;52:397-404.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976;72:248-54.
9. Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 1991;564: 203-19.
10. Levant B. The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol Rev 1997;49:231-52.
11. Koeltzow TE, Xu M, Cooper DC, et al. Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J Neurosci 1998;18:2231-8.
12. Devoto P, Collu M, Muntoni AL, et al. Dopaminergic system. Synapse 1995;20:153-5.
13. Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 1992;13:177-84.
14. Mizuo K, Narita M, Sakata M, Suzuki T. [Abstract]. The 23rd Japan Narcotic Research Conference, 2002, pp. 1-3.
15. Ferguson SSG. Evolving concepts in G-protein coupled receptor endocytosis: the role of receptor desensitization and signaling. Pharmacol Rev 2001;53:1-24.
16. Mason JN, Kozell LB, Neve KA. Regulation of dopamine D1 receptor trafficking by protein kinase A-dependent phosphorylation. Mol Pharmacol 2002;61:806-16.
17. Rogue P, Zwiller J, Malviya AN, Vincendon G. Phosphorylation by protein kinase C modulates agonist binding to striatal dopamine D2 receptors. Biochem Int 1990;22:575-82.
18. Ito K, Haga T, Lameh J, Sadee W. Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5. Eur J Biochem 1999;260:112-19.
19. Kabbani N, Negyessy L, Lin R, Goldman-Rakic P, Levenson R. Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J Neurosci 2002;22:8476-86.